Microplate assays for high-throughput screening

Current Opinion in Drug Discovery and Development

Volumn 1, Issue 1, 1998, Pages 85-91

  Nakayama, Grace R ^a  

^a IRORI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008774595     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Burbaum JJ, Sigal NH: New technologies for highthroughput screening. CurrOpin Chem Biol (1997) 1:72-78.
2. Beggs M: Use of a two-armed Zymark® robot for highthroughput screening. J Biomol Screening (1997) 2:133-135.
3. Banks M, Binnie A, Fogarty S: High-throughput screening using fully Integrated robotic screening. J Biomol Screening (1997)2:71-78.
4. Houston JG, Banks M: The chemical-biological interface: developments in automated and miniaturised screening technology. CurrOpin Biotechnology (1997) 8:734-740.
5. Bronstein I, Fortin J, Stanley PE, Stewart GS, Kricka LJ: Chemiluminescent and bioluminescent reporter gene assays. Anal Biochem (1994) 219:169-81.
6. Dhundale A, Goddard C: Reporter assays in the high-throughput screening laboratory: a rapid and robust first look? JBiomol'Screening (1996) 1:115-118.
7. Suto CM, Ignar DM: Selection of an optimal reporter gene for cell-based high-throughput screening assays. J Biomol Screening (\3°ïï) 2:7-9.
8. Little J: Enzyme-labeled immunoassay. In: Immuno-assays, Edwards R (Ed), Wiley, Chichester(1996):47-62.
9. Ellsmore VA, Teoh AP, Ganesan A: A high-throughput enzyme-linked immunosorbent assay for inhibitors of the interaction between retinoblastoma protein and the Leu-XCys-X-Glu Motif. JBiomol Screening(1997) 2:207-211.
10. Bertozzi CR, Singer MS, Rosen SD: An ELISA for selectins based on binding to a physiological ligand. JImmunol Meth (1997)203:157-165.
11. Sarubbi E, Yanofsky SD, Barren RW, Denaro M: A cell-free, nonisotopoic, high-throughput assay for inhibitors of Type-1 interieukin-1 receptor. Anal Biochem (1996) 237:7075.
12. King 1C, Feng M, Catino JJ: High-throughput assay for inhibitors of the epidermal growth factor receptor-associated tyroslne kinase. Life Sciences (1993) 53:1465.
13. Angeles TS, Steffier C, Bartlett BA, Hudkins RL, Stephens RM, Kaplan DR, Dionno ÇA: Enzyme-linked immunosorbent assay for trkA tyrosine kinase activity. AnalBiochem (1996) 236:49-55.
14. Lehel C, Daniel-lssakani S, Brasseur M, Strulovici B: A chemiluminescent microtiter plate assay for sensitive detection of protein kinase activity. Anal Biochem (1997) 244:340-346. A non-radioactive enzyme immunoassay using chemilum-inescence detection lor assaying protein kinase activity.
15. Takeshita N, Kakiuchi N, Kanazawa T, Komoda Y, Nishizawa M, Tani T, Shimotohno K: An enzyme-linked immunosorbent assay for detecting proteolytic activity of hepatitis C virus proteinase. AnalBiochem (1997) 247:242-246.
16. Edwards E: Radiolabeled immunoassays. In: Immunoassays, Edwards R (Ed), Wiley, Chichester (1996):33-46.
17. Toney JH, Hammond GG, Letting G, Pryor KD, Wu JK, Cuca GC, Pomliano DL: Soluble penicillin-binding protein 2a: β-lactam binding and inhibition by non-β-lactams using a 96-23II format. Anal Biochem (1998) 255:113-119.
18. Pitt AM, Lee C: High-throughput screening protein kinase assays optimized for reaction, binding, and detection totally within a 96-well plate. J Biomol Screening (1996) 1:47-50.
19. Ramdas L, Budde RJA: An automated liquid-phase assay for quantitation of protein tyrosine kinase activity. Anal Biochem (1997) 254:291-293.
20. Hart HE, Greenwald EB: Scintillation proximity assay (SPA) a new method of immunoassay. Direct and inhibition mode detection with human albumin and rabbit antihuman albumin. Mot Immunol'(1979) 16:265-267.
21. McCaffrey C, Powers G, Talbot MK: Utilization of the ORCA to completely automate scintillation proximity assays. J Biomol Screening (1996) 1:187-190
22. Stamper ML, Kalter K, Hubbard F, Brand, TG, Dandakar S, Brown M: Mechanical and control improvements to an automated SPA/assay to Increase system reliability. J BiomolScreening(1998) 3:63-65.
23. Baum EZ, Johnston SH, Bebemitz G, Gluzman Y: Development of a scintillation proximity assay for human cytomegalovirus protease using "phosphorus. Anal Biochem (1996) 237:129-134.
24. cdc2/cyclin B kinase-mediated phosphorylation of peptides derived from histone H1 using phoshocellulose filter ginding and scintillation proximity assays. J'Biomol'Screening'(1997) 2:25-32.
25. Braunwalder AF, Wennogle L, Gay B, Lipson KE, Sills MA: Application of scintillating microtiter plates to measure phosphopeptide interactions with the GRB2-SH2 binding domain. J Biomol Screening (1996) 1:23-26.
26. Braunwalder AF, Yarwood DR, Hall T, Missbach, Lipson KE, Sills MA: A solid-phase assay for the determination of protein tyrosine kinase activity of c-src using scintillating microtitration plates. Anal Biochem (1996) 234:23-26.
27. Nakayama GR, Nova MP, Parandoosh 2: A scintillating microplate capture assay for the assessment of protein kinase activity. JBiomol'Screening(1998) 3:29-34.
28. Checovich WJ, Böiger RE, Burke T:% Fluorescence polarization: A new tool for cell and molecular biology. Nature (1995) 375:254-256.
29. Wu P, Brasseur M, Schindler U: A high-throughput STAT binding assay using fluorescence polarization. Anal Biochem (1997) 249:29-36.
30. Lynch BA, Loiacono KA, Tiong CL, Adams SE, MacNeil IA: A fluorescence polarization based Src-SH2 binding assay. Anal Biochem (1997) 247:77-82.
31. Seethala R, Menzel R: A homogeneous, fluorescence polarization assay for Src-family ty rosi ne kinases. Anal Biochem (1997) 253:210-218. The first example of using fluorescence polarization to measure protein tyrosine kinase activity.
32. Schade SA, JoIIey ME, Sarauer BJ, Simonson LG: BODIPY-α-casein: a pH-independent protein substrate for protease assays using fluorescence polarization. Anal Biochem (1996)243:1-7.
33. JoIIey ME: Fluorescence polarization assays for the detection of proteases and their Inhibitors. J Biomol Screening (1996) 1:33-38. This article also describes the theory behind fluorescence polarization.
34. Levine LM, Michener ML, Toth MV, Holwerda BC: Measurement of specific protease activity utilizing fluorescence polarization. Anal Biochem (1997) 247:83-88.
35. Selvin PR: Fluorescence resonance energy transfer. Meth Enzymo/(\995) 246:300-334. A comprehensive review on this subject. See also [36].
36. Legg RM: Fluorescence resonance energy transfer. Curr Opfn Biotechnology (1995) 6:103-110. A comprehensive review on this subject. See also [35].
37. Taliani M, Bianchi E, Narjes F, Fossatelli M, Urbani A, Steinkühler C, De Francesco R, Pessi A: A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. Anal Biochem (1996) 240:60-67.
38. Wang GT, Chung CC, Holzman TF, Krafft GA: A continuous fluorescence assay of renin activity. Anal Biochem (1993) 210:351-359
39. Mataoshi ED, Wang GT, Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science (1990) 247:954-958.
40. Youn HJ, Terpetschnig E, Szmacinski H, Lakowicz JR: Fluorescence energy transfer immunoassay based on a long-lifetime luminescent metal-ligand complex. Anal Biochem (1995) 232:24-30.
41. Holzwarth AR: Time-resolved fluorescence spectro-scopy. Meth Enzymo/(]335) 246:334-362 A comprehensive review on this subject.
42. Dickson EF, Pollak A, Diamandis EP: Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. Pharmacol 77?e/-(1995) 66:207-235.
43. Yuan J, Wang G, Kimura H, Matsumoto K: Highly sensitive time-resolved fiuorolmmunoassay of human immunoglobulin E by using a new europium fluorescent chelate as a label. Anal Biochem (1997) 254:283-287.
44. Braunwalder AF, Yarwood DR, Sills MA, u'pson KE: Measurement of the protein tyroslne kinase activity of c-src using time-resolved fluorometry of europium chelates. Anal Biochem (1996) 238:159-164.
45. Kolb JM, Yamanaka G, Manly SP: Use of a novel homogeneous fluorescent technology in high-throughput screening. J Biomol Screening (1996) 1:203-210. The first example of time resolved fluorescence resonance energy transfer performed in microplates.
46. Lazaro JE, Gay F: Plasmodium falciparunr. in vitro cytotoxicity testing using MTT. JBiomol Screening (1998) 3:49-53.
47. Mossmann T: Rapid colortmetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. JImmunolMethods (1983) 65:55-63.
48. Goodwin CJ, Holt SJ, Dowries S, Marshall NJ: Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. J Immunol Methods (1995) 179:95-103. Of these tetrazolium compounds, MTS is more stable than XTT.
49. Kondo T, Wada K, Kawashima M, Sato Y, Yamauchi M: Highsensitivity antitumor drug sensitivity testing. Oncology (1994)41:535-539.
50. Papazisis KT, Geromichalos GD, Dimilriadis KA, Kortsaris AH: Optimization of the sulforhodamine B colorimetric assay. J Immunol Methods (1997) 208:151 -158.
51. Natarajan N, Shambaugh, III GE, Elseth KM, Haines GK, Radoscvich JA: Adaptation of the diphenylamine (DPA) assay to a 96-well plate tissue culture format and comparison with the MTT assay. Biotechniques (1993) 17:166-171.
52. th Ed (1996):369-370.
53. Rago R, Milchen J, Wilding G: DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal Biochem (1990) 191:31-34.
54. Rat P, Korwin-Zmijowska C, Warnet JM, Adolphe M: New in vitro fluorimetric microtitration assays for toxicological screening of drugs. CellBiol Toxical (1994) 10:329-337.
55. Sellers JR, Cook S, Goldmacher VS: A cytotoxicity assay utilizing a fluorescent dye that determines accurate surviving fractions of cells. JImmunolMeth (1994) 172:255.
56. Fields RD, Lancaster MV: Dual attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotechnology Lab (1993) 11:48-50.
57. 2HJthymldine incorporation assay. J Immunol Methods (1994)170:211-224. This is the first comprehensive paper comparing the utility of the Alamar Blue assay to other traditional assays.
58. Collins LA, Franzblau SG: Microplate Alamar Blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacteriutn tuberculosis and Mycobacterium avium. Antimicrobial Agents and Chemotherapy(1997) 41:1004-1009.
59. Zhi-Jun Y, Sriranganathan N, Vaught T, Arastu SK, Ansar Ahmed S: A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies. J Immunol Methods (1997) 210:25-39.
60. Nakayama GR, Caton MC, Nova MP, Parandoosh Z: Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J'Immunol'Methods(1997) 204:205-208.
61. Janzen B, Domanico P: The 384-well plate: pros and cons. J Biomol Screening (\336) 1:65-64.
62. Kob AJ, Newmann K: Beyond the 96-well microplate: Instruments and assay methods or the 384-well format. J Biomol Screening (\
63. Comley JCW, Binnie A, Bonk C, Houston JG: A 384-HTS for human Factor Vila: comparison with 96- and 864-well formats. J BiomolScreening (1997) 2:171-178.
64. Knebel G: High-throughput screening with 1536 wells. Am Biotech Laboratory(1998) 16(4):22-24. Complete descriptions of the standardized 384 and 1536 well plates are given here.
65. Burbaum JJ, Sigal NH, Kirk G, Affleck R, Yang K, Skwish S, Kirn A, Pryor T, Gasteb F: High-throughput screening in microliter volumes using 1536 well plates: a systems approach. Lab Automation '98, January 17-21, 1998, San Diego, CA.
66. Oldenburg KR, Zhang J-H, Chen T, Maffia 111 A, Blom KF, Combs AP, Chung TOY: Assay miniaturization for ultrahigh-throughput screening of combinatorial and discrete compound libraries: a 9600-well (0.2 microliter) assay system. JBiomol Screening (1998) 3:55-62. This the first published example of an ultra-high density plate for screening bead-based combinatorial libraries using a CCD camera for detection.
67. DeWitl SH: Miniaturized chip-based systems for ultra high-throughput drug discovery. High-throughput screening: novel approaches and new technologies for accelerated drug discovery, IBCmeeting, April 20-21,1998, San Diego, CA.
68. Martin CS, Bronstein I: Imaging of chemiluminescent signals with cooled CCD camera systems. J Biolumin Chemum/r (1994) 9:145-153.
69. Schroeder KS, Neagle BD: FLIPR: A new instrument for accurate, high-throughput optical screening. J Biomol Screening (1996) 1:75-80.
70. Izzo JA: Quantitative imaging of assays in miniaturized plate formats. High-throughput screening: novel approaches and new technologies for accelerated drug discovery, IBC meeting, April 20-21,1998, San Diego, CA.